Company: HCTI
Filing Date: 2025-02-25
Form Type: PRE 14A
Source: 0001213900-25-017146
Chunk: 17

Company: Healthcare Triangle, Inc.
Filing Date: 2025-02-25
Form: PRE 14A
Chunk 17
---
 material adverse effect on us.

Board Committees

Our Board of Directors has established three
standing committees: audit, leadership and compensation, and nominating and corporate governance. We have appointed persons to the Board
of Directors and committees of the Board of Directors as required to meet the corporate governance requirements of the Nasdaq. The audit
committee, compensation committee and nominating and corporate governance committee all operate under charters approved by our Board
of Directors (copies of which can be found on our website by visiting https://www.healthcaretriangle.com/investors/governence/policies.
During the fiscal year ended December 31, 2024, the audit committee met [●] times, the compensation committee met [●], and
the nominating and corporate governance committee met [●] times. During their respective terms of service, each director attended
at least 75% of all meetings of the committees on which they then served, which were held during 2024.

Our Board of Directors may from time to time
establish other committees.

Board and Committee Evaluations

The nominating and corporate governance committee
intends to establish the Board and committee evaluation process and may determine to use an independent third-party evaluation process
from time to time in the future. No board or committee evaluations were undertaken in 2024.

Director Attendance at Annual Meeting of Stockholders

Directors are encouraged to attend the annual meeting of stockholders
to the extent practicable. We held an annual meeting of stockholders in 2023 as we were a public company.

<div align='center'>10</div>

Audit Committee

We have a separately designated standing audit
committee of our Board of Directors, as defined in Section 3(a)(58)(A) of the Securities Exchange Act of 1934, as amended (“Exchange Act”). The audit committee is currently comprised of three independent directors: Ronald McClurg, Jainal Bhuiyan, Dave Rosa.
Mr. McClurg is the Chair of our audit committee. Our Board of Directors have determined that each of the members of our audit committee
is “independent” within the meaning of the rules of the Nasdaq and the SEC, including for audit committee purposes, and that
each of the members of our audit committee is financially literate and has accounting or related financial management expertise, as such
qualifications are defined under the rules of the Nasdaq. In addition, our Board of Directors has determined that Mr. McClurg is an “audit
committee financial expert” as defined by the